CDER New October 19, 2018

October 18, 2018

• FDA D.I.S.C.O.: A new drug approval for IDH1 positive relapsed or refractory Acute Myeloid Leukemia - Podcast
• FDA D.I.S.C.O.: A new drug approval for IDH1 positive relapsed or refractory Acute Myeloid Leukemia - Transcript
• FDA Drug Shortages
  • Diltiazem Hydrochloride ER (Twice-a-Day) Capsules (New - Currently in Shortage)
  • Ondansetron Hydrochloride Injection (Updated = Currently in Shortage)